Applied DNA Sciences (NASDAQ:APDN)报告季度每股亏损$(0.56)，未达到分析师一致预期的$(0.28)，相差100%。这比去年同期每股亏损$(0.09)减少了522.22%。公司报告季度销售额为$1.20百万，超出分析师一致预期的$1.10百万，超出8.67%。这比去年同期的销售额$891.16千增加了34.32%。
以上内容来自Benzinga Earnings专栏，原文如下：
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.28) by 100 percent. This is a 522.22 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $1.20 million which beat the analyst consensus estimate of $1.10 million by 8.67 percent. This is a 34.32 percent increase over sales of $891.16 thousand the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。